Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property
Global Hemp Group Announces Final Payment Made Relating to the Exclusive Licensing of Apollon Formularies PLC Patents and Intellectual Property
Vancouver, British Columbia--(Newsfile Corp. - April 4, 2023) - GLOBAL HEMP GROUP INC. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) ("GHG" or the "Company") is pleased to announce that it has completed its contractual obligations relating to the first stage of the binding Letter of Intent ("LOI") and the Exclusive Licensing Agreement for the patents and Intellectual Property ("IP") of Apollon Formularies plc ("Apollon"), by advancing a final payment of US$150,000 to Apollon (for further information on the binding LOI and the Exclusive Licensing Agreement see the Company's news releases of January 11, 2023, January 23, 2023 and March 21, 2023).
溫哥華,不列顛哥倫比亞省-(Newsfile Corp.-2023年4月4日)-環球大麻集團公司。(CSE:GHG)(場外粉色股票代碼:GBHPF)(倫敦證券交易所股票代碼:GHG)(以下簡稱“GHG”或“公司”)欣然宣佈,通過向Apollon預付150,000美元(有關具有約束力的意向書和獨家許可協定的更多資訊,請參閱公司於2023年1月11日、2023年1月23日和2023年3月21日發佈的新聞稿),公司已經完成了與Apollon配方公司(“Apollon”)的專利和知識產權獨家許可協定第一階段有關的合同義務。
Apollon is a UK-based international pharmaceutical company developing cancer treatments from natural biologics, including cannabinoids, functional mushrooms, psychedelic mushrooms and most importantly combinations of these compounds. These formulations have demonstrated significant success in independent, third-party pre-clinical testing.
Apollon是一家總部位於英國的國際製藥公司,利用天然生物製劑開發癌症治療方法,包括大麻類化合物、功能性蘑菇、迷幻蘑菇以及最重要的這些化合物的組合。這些配方在獨立的第三方臨床前測試中取得了顯著的成功。
Under the Exclusive Licensing Agreement, GHG has acquired the exclusive right to Apollon's patents and IP for the United States, Canada, Mexico, the European Union, Morocco and Israel, which include:
根據獨家許可協定,GHG已獲得Apollon在美國、加拿大、墨西哥、歐盟、莫耳洛哥和以色列的專利和知識產權的獨家權利,其中包括:
Compositions and Methods for Treatment of Cancers;
治療癌症的組合物和方法;
Compositions and Methods for Treatment of Inflammation;
治療炎症的組合物和方法;
Methods for Treatment of Human Cancers Using Mushroom Compositions;
利用蘑菇組合物治療人類癌症的方法;
BIOENSIS Pre-clinical Data reflecting independent 3Dimensional cell culture testing of cannabinoid and mushroom formulations included in the patent applications.
BIOENSIS臨床前數據反映了專利申請中包括的大麻素和蘑菇製劑的獨立三維細胞培養測試。
The Company is now engaged in discussions with legally licensed manufacturers, distributors and retail partners in the United States and Canada to monetize this IP by sublicensing it on both an exclusive and non-exclusive basis.
該公司目前正在與美國和加拿大的合法許可製造商、分銷商和零售合作夥伴進行談判,通過以獨家和非獨家的方式對該知識產權進行再許可來實現其貨幣化。
Further, with the completion of this initial stage of the binding LOI, GHG will focus on completing due diligence of the Apollon assets, in order for the Company to determine if it will execute its option to acquire the entirety of the assets, per the binding LOI dated January 9, 2023. Due diligence and exercise of the option is required to be completed by April 28, 2023, as announced in the Company's news release of March 20, 2023, unless waived by mutual agreement of the Parties prior to that date.
此外,隨著具有約束力的意向書的第一階段完成,GHG將專注於完成對Apollon資產的盡職調查,以便公司確定是否將根據日期為2023年1月9日的具有約束力的意向書執行其收購全部資產的選擇權。盡職調查和行使期權的工作必須在2023年4月28日之前完成,如公司在2023年3月20日的新聞稿中所宣佈的那樣,除非在該日期之前經雙方同意放棄。
The Company also announces that it has entered into a loan agreement at arm's length whereby it has received an amount of USD$150,000 on April 3, 2023. The loan is unsecured, bears interest at a rate of 12.0% per annum and is due on or before July 31, 2023.
該公司還宣佈,它已達成一項獨立貸款協定,於2023年4月3日收到150,000美元。這筆貸款是無抵押的,年利率為12.0%,2023年7月31日或之前到期。
About Global Hemp Group Inc.
環球大麻集團公司簡介
Global Hemp Group Inc. (CSE: GHG) (OTC Pink: GBHPF) (FSE: GHG) is focused on developing and promoting hemp-based products that are sustainable, environmentally friendly, and have a positive impact on society. To further support and innovate, GHG has established a R&D Division to actively pursue the development of Intellectual Property that can be patented for implementation at its projects and beyond. The Division is led by Prof. Víctor M. Castaño, Ph.D. whose career has focused in the areas of applied science and technology. The R&D team is initially focused on development of Environmentally Friendly Construction Materials, Nanofertilizers and Enhanced Cannabinoid Extraction from Hemp.
全球大麻集團公司(CSE:GHG)(場外交易市場:GBHPF)(FSE:GHG)專注於開發和推廣以大麻為基礎的產品,這些產品是可持續、環保和對社會有積極影響的。為了進一步支持和創新,GHG成立了一個研發部門,積極從事知識產權的開發,這些知識產權可以在其專案和其他專案中獲得專利實施。該司由Víctor M.Castaño教授領導,他的職業生涯專注於應用科學和技術領域。研發團隊最初專注於開發環境友好型建築材料、納米肥料和從大麻中增強大麻素提取。
For Further Information Contact Global Hemp Group
欲瞭解更多資訊,請聯繫環球大麻集團
Investor Relations
投資者關係
Tel: 778-726-2900
電話:778-726-2900
info@globalhempgroup.com
郵箱:info@lobalhempgroup.com
Cautionary Note Regarding Forward-Looking Statements
有關前瞻性陳述的注意事項
Certain information set forth in this news release may contain forward-looking statements that involve substantial known and unknown risks and uncertainties. These forward-looking statements are subject to numerous risks and uncertainties, certain of which are beyond the control of Global Hemp Group Inc., including, but not limited to, the impact of general economic conditions, industry conditions, volatility of commodity prices, currency fluctuations, dependence upon regulatory approvals, the availability of future financing and exploration risk, and the legality of cannabis and hemp. Readers are cautioned that the assumptions used in the preparation of such information, although considered reasonable at the time of Page 2 of 2 preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. Except as required by law, Global Hemp Group Inc. disclaims any intention and assumes no obligation to update or revise any forward-looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward-looking statements or otherwise.
本新聞稿中陳述的某些資訊可能包含前瞻性陳述,這些陳述涉及大量已知和未知的風險和不確定性。這些前瞻性聲明會受到許多風險和不確定性的影響,其中某些風險和不確定性是Global hemp Group Inc.無法控制的,包括但不限於總體經濟狀況、行業狀況、大宗商品價格的波動、匯率波動、對監管部門批准的依賴、未來融資和勘探風險的獲得以及大麻和大麻的合法性。請讀者注意,編制此類資訊時使用的假設雖然在編制第2頁時被認為是合理的,但可能被證明是不準確的,因此不應過度依賴前瞻性陳述。除非法律另有要求,否則Global hemp Group Inc.無意更新或修改任何前瞻性陳述,以反映實際結果,無論是由於新資訊、未來事件、假設的變化、影響此類前瞻性陳述的因素的變化或其他原因。
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.
CSE未對本新聞稿的充分性或準確性進行審查,也不承擔任何責任。
To view the source version of this press release, please visit
要查看本新聞稿的源版本,請訪問